Page 3 - Dcph News Today

By Dean Seal Shares of Deciphera Pharmaceuticals jumped after the company said a trial of vimseltinib, its treatment for tenosynovial giant cell tumors, met...

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $10.24 and last traded at $10.55, with a volume of 14011 shares changing hands. The stock had previously closed at $10.57. Analyst Ratings Changes DCPH has been the subject of a […]

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have assigned a buy recommendation to the […]

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) traded down 6.3% on Wednesday . The stock traded as low as $14.44 and last traded at $14.51. 150,124 shares were traded during mid-day trading, a decline of 77% from the average session volume of 645,505 shares. The stock had previously closed at $15.48. Wall […]

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) released its earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.05, Briefing.com reports. Deciphera Pharmaceuticals had a negative net margin of 129.90% and a negative return on equity of 47.99%. The company had revenue […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price was down 3.9% on Monday . The stock traded as low as $13.16 and last traded at $13.18. 40,322 shares traded hands during trading, a decline of 94% from the average daily volume of 669,164 shares. The stock had previously closed at $13.71. Analysts Set […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 3,790,000 shares, a drop of 14.1% from the June 15th total of 4,410,000 shares. Based on an average daily trading volume, of 533,300 […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 4,310,000 shares, an increase of 14.9% from the May 15th total of 3,750,000 shares. Based on an average daily volume of 622,700 shares, the […]

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Rating) and ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Institutional & Insider Ownership 72.7% of Deciphera Pharmaceuticals shares […]